Scientific Validation and Clinical Application of Lung Cancer Organoids
Lung cancer organoid (LCO) is a novel model of lung cancer that facilitates drug screening. However, the success rate of LCOs varies from 7% to 87%, and the culture medium compositions are markedly different. Airway organoid media can be used for LCO cultures, but this promotes the overgrowth of nor...
Guardado en:
Autores principales: | Dahye Lee, Yoonjoo Kim, Chaeuk Chung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/44fd42bd9d9d45f583b66114e684648b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Authentic Modeling of Human Respiratory Virus Infection in Human Pluripotent Stem Cell-Derived Lung Organoids
por: M. Porotto, et al.
Publicado: (2019) -
Methodologies for Generating Brain Organoids to Model Viral Pathogenesis in the CNS
por: Hannah K. Hopkins, et al.
Publicado: (2021) -
Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy
por: Fan Chen, et al.
Publicado: (2021) -
Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways
por: Hefei Li, et al.
Publicado: (2021) -
Current Status of Breast Organoid Models
por: Srivarshini Cherukupalli Mohan, et al.
Publicado: (2021)